GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2022

Top Holdings60 positions

Checking export access…
Activity:

TENET HEALTHCARE CORP

6.4M$548.5M11.1%$17.82+382.48%
14 qtrssince 2018-Q4
Decreased
0

THE CIGNA GROUP

1.6M$382.4M7.7%$190.71+15.61%
14 qtrssince 2018-Q4
Increased
82

GLOBAL PMTS INC

2.4M$322.4M6.5%$153.86-15.07%
6 qtrssince 2020-Q4
Increased
68

MCKESSON CORP

936,041$286.6M5.8%$144.46+108.54%
14 qtrssince 2018-Q4
Decreased
0

DXC TECHNOLOGY CO

7.5M$246.3M5.0%$42.50-23.22%
14 qtrssince 2018-Q4
Increased
78

FISERV INC

2.1M$217.3M4.4%$104.94-2.67%
11 qtrssince 2019-Q3
Increased
91

BAUSCH HEALTH COS INC

9.3M$211.5M4.3%$22.53+2.86%
14 qtrssince 2018-Q4
Decreased
0

BAXTER INTL INC

2.2M$171.4M3.5%$74.57-2.68%
9 qtrssince 2020-Q1
Increased
56

US FOODS HLDG CORP

4.4M$166.3M3.4%$36.60+2.80%
2 qtrssince 2021-Q4
Increased
90

COCA-COLA EUROPACIFIC PARTNE

2.8M$138.4M2.8%$46.99-7.73%
5 qtrssince 2021-Q1
Increased
55

UBER TECHNOLOGIES INC

3.8M$136.9M2.8%$42.52-13.97%
4 qtrssince 2021-Q2
Increased
72

AMAZON COM INC

40,962$133.5M2.7%$164.76-1.07%
2 qtrssince 2021-Q4
Increased
84

APTIV PLC

1.1M$131.7M2.7%$135.41-9.78%
6 qtrssince 2020-Q4
Increased
83

MERITOR INC

3.5M$126.1M2.6%——
14 qtrssince 2018-Q4
Increased
65

CENCORA INC

752,648$116.4M2.4%$93.50+59.63%
14 qtrssince 2018-Q4
Decreased
0

DUPONT DE NEMOURS INC

1.5M$113.6M2.3%$84.91+0.03%
6 qtrssince 2020-Q4
Increased
53

CENTENE CORP DEL

1.1M$92.1M1.9%$72.42+16.25%
4 qtrssince 2021-Q2
Decreased
0

ENCOMPASS HEALTH CORP

1.3M$91.4M1.9%$54.48-0.09%
3 qtrssince 2021-Q3
Increased
71

UNIVERSAL HLTH SVCS INC

618,871$89.7M1.8%$115.43+23.71%
14 qtrssince 2018-Q4
Decreased
0

BROOKDALE SR LIVING INC

12.6M$88.7M1.8%$6.32+12.40%
14 qtrssince 2018-Q4
Increased
57
$4.9B
AUM
60
Positions
Q1 2022
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+34%Q4'20$4.3B+38%Q1'21$5.9B+2%Q2'21$6B-9%Q3'21$5.5B-16%Q4'21$4.6B+6%Q1'22$4.9B
Activity profile
$ moved · Q1'22
New11%Increased48%Decreased29%Exited12%
Composition
Equity vs derivatives
Equity99%Puts0%Calls1%
Holding period
Avg 1.8 years
<1Q10%1-4Q25%1-2Y17%2Y+48%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.9B across 60 positions as of Q1 2022. Top holdings: THC (11.1%), CI (7.7%), GPN (6.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q1 2022 Summary

Active quarter - 8 new positions, 4 exits, 26 increased. Top move: FISV (INCREASED, conviction 91). Portfolio: $4.9B across 60 positions.

Top holdings by portfolio weight

Total AUM$5B
THC11.11%
CI7.74%
GPN6.53%
MCK5.80%
DXC4.99%
FISV4.40%
BHC4.28%
BAX3.47%
USFD3.37%
CCEP2.80%
Other2.77%

Portfolio allocation by GICS sector

Sectors8
Healthcare48.74%
Unknown10.86%
Technology9.62%
Industrials9.48%
Consumer Cyclical7.81%
Basic Materials6.43%
Consumer Defensive6.21%
Communication Services0.84%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L67
Conviction48
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGlobal Payments Inc
Q2 2025 → Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAmazon.com Inc
Q3 2025 → Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 → Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used